The biotechnology company has completed the acquisition of the remaining 10% stake in its US subsidiary, aligning with its global strategy and supporting growth in the viral vector manufacturing market.
The healthcare company announces a non-executive director has purchased additional shares.
The biotechnology company provides an update ahead of its Annual General Meeting, reiterating its financial guidance for the year.
The biotechnology company has announced a change in shareholding, with Briarwood Chase Management LLC increasing its stake to over 13%.
The biotechnology company has launched an advisory board to provide strategic insight on technology priorities and innovation opportunities.
The biotechnology company has granted share options to its senior management team as part of their long-term incentive plans.
The healthcare company has announced a transaction by a person closely associated with a director.
The biotechnology company has disclosed a change in major shareholding, with Briarwood Chase Management LLC now holding over 12% of the company's shares.
The biotechnology company has announced the date and details for its 2025 Annual General Meeting.
The biotechnology company has reported a change in major shareholding, with Briarwood Chase Management LLC now holding over 11% of the voting rights.